CLINICAL_TRIALS
research
· 2026-03-12
Clinical Trial Update: Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers [NA]
Summary
Clinical trial evaluating noncombustible nicotine delivery systems as potential harm reduction tools for persistent cigarette smokers. Sponsor: Abramson Cancer …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: E-cigarette Use, Cigarette Smoking | NA | Status: RECRUITING